Vertex Pharmaceuticals Inc. sell Canaccord Genuity Group Inc.
Start price
24.01.24
/
50%
€401.90
Target price
24.01.25
€346.79
Performance (%)
4.37%
End price
25.01.25
€419.45
Summary
This prediction ended on 25.01.25 with a price of €419.45. With a performance of 4.37%, the SELL prediction by Canaccord_Genuity_Gr for Vertex Pharmaceuticals Inc. was trending in the wrong direction Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 5.141% | 5.141% | -3.235% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "sell" rating. They now have a $379.00 price target on the stock, up previously from $332.00.
Ratings data for VRTX provided by MarketBeat